Medical Device News Magazine

First-Ever BioMech Clinical Motion Lab Opens in Atlanta to Accelerate Traumatically Injured Patients’ Recovery Using AI-driven Motion Science Technology in Clinic and at Home

BioMech, Atlanta’s Independent Neurodiagnostic Clinic joins forces to help patients and health care providers quantitatively measure and monitor function

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

BioMech Health, LLC, a division of BioMech Holdings, LLC, announced that Atlanta-based Independent Neurodiagnostic Clinic (INC) and BioMech have partnered to deliver state-of-the-art clinical motion analytics to advance patient treatment. The groundbreaking motion lab allows physicians to quantitatively measure and monitor patients’ pre-and post-treatment function to determine appropriate treatment and assess progress to improve recovery. The system also provides real-time biofeedback to assist recovery, anytime, anywhere.

The BioMech Clinical Motion Lab located at the Palisades at West Paces in Atlanta, Georgia, provides access to critical services such as neurology, neuropsychiatry, speech pathology, physiatry, and orthopaedics/spine. This multispecialty motion lab is focused on helping patients by restoring function during the treatment process. The centralized laboratory will be available to clinicians in the surrounding area.

The ability to evaluate sudden or gradual changes in movement can be vital to the early diagnoses, treatments, and management of traumatic injuries. INC uses BioMech’s advanced technological platform, BioMech Lab, driven by its artificial intelligence and machine learning platform, Coretex.ai, to make it possible to use motion as a functional biomarker and endpoint for many treatments. The system instantly captures and streams three-dimensional motion data from single or multiple sensors with wireless, noninvasive, self-calibrating technology.

“Our technology’s capability to monitor a patient’s function in office and then at the patient’s home over a period of time is a catalyst for change in healthcare – signifying cost savings for patients and payers,” says Carter Brown, CEO, BioMech Health. “Because BioMech Lab can set baselines in the office and then monitor a patient’s progress at home, physicians can actively ascertain patient progress without having to incur the inconvenience and costs of an office visit.”

“INC and BioMech are partnering to optimize the best of ‘Classical Old School Medicine’ by combining it with state-of-the-art quantitative medical technology to produce measurable outcomes,” said L.D. Empting MD., Director, Independent Neurodiagnostic Clinic. “The BioMech Clinical Motion Lab helps us do that by providing the tools, visualizations and data needed to reprogram neural pathways and eliminate maladaptive motion patterns that inhibit achieving fuller functional recoveries.

Critically Injured Patient Finds Vast Improvement in Functionality with BioMech Lab Systems

Robert, a professional commercial vehicle driver and former military personnel, became an INC patient after a serious fall left him with post-concussion syndrome, affecting his memory, cognitive function, and personality. The impact also injured his top vertebrae and the ligaments that control the skull, causing severe balance issues. In addition to a multi-treatment approach including hyperbaric oxygen and specialized chiropractic, Robert has been using the BioMech Lab system in the Clinical Motion Lab and at home to help regain functionality.

“What I like is that the BioMech system is able to show me immediately whether or not I’ve improved or even if I have gone backwards or stayed the same,” says Robert. “I’ve been operated on so many times and I’ve been through so much physical therapy. Watching myself balance on screen makes it easier to understand and know what to do. Now that I am at a point where I am also practicing at home, alone, the BioMech system really helps mentally because you can look at the numbers and suddenly you’ve got tangible proof that you’re getting better.”

A key to Robert’s returning gait and balance functionality is BioMech’s powerful biofeedback function. “The interactive biofeedback brings an element of functional medicine and gamification to recovery, which is a powerful motivator for individuals like Robert who respond best to visual cues,” said BioMech Founder Dr. Frank Fornari. “It is a key differentiator of the BioMech system, and why the BioMech Clinical Lab should be part of every neurology, orthopaedic and physiatry clinic.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”